Research Summary
Favipiravir is an antiviral medication used in the treatment of certain viral infections. It belongs to a class of drugs known as nucleoside analogs, which work by interfering with the replication and transcription of viral genetic material, inhibiting the spread of the virus within the body. Favipiravir gained attention during the COVID-19 pandemic as a potential treatment option, although its effectiveness in treating the virus remains a subject of ongoing research and clinical trials. In addition to its potential use for COVID-19, favipiravir has been approved for the treatment of influenza in some countries and is being investigated for its antiviral properties against other viral infections. Its use should be supervised by healthcare professionals, as it may have side effects and drug interactions that need to be carefully managed.
According to DIResearch's in-depth investigation and research, the global Favipiravir market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Favipiravir include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Hisun Pharm, Sun Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Favipiravir. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Favipiravir market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Favipiravir market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Favipiravir industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Favipiravir Include:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Hisun Pharm
Sun Pharma
Favipiravir Product Segment Include:
Brand Drug
Generic Drug
Favipiravir Product Application Include:
Influenza Viruses
COVID-19
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Favipiravir Industry PESTEL Analysis
Chapter 3: Global Favipiravir Industry Porter's Five Forces Analysis
Chapter 4: Global Favipiravir Major Regional Market Size and Forecast Analysis
Chapter 5: Global Favipiravir Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Favipiravir Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Favipiravir Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Favipiravir Market Overview 1.1 Product Definition and Statistical Scope 1.2 Favipiravir Product by Type 1.2.1 Global Favipiravir Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Brand Drug 1.2.3 Generic Drug 1.3 Favipiravir Product by Application 1.3.1 Global Favipiravir Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Influenza Viruses 1.3.3 COVID-19 1.3.4 Others 1.4 Global Favipiravir Market Revenue Analysis (2019-2030) 1.5 Favipiravir Market Development Status and Trends 1.5.1 Favipiravir Industry Development Status Analysis 1.5.2 Favipiravir Industry Development Trends Analysis 2 Favipiravir Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Favipiravir Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Favipiravir Market Analysis by Regions 4.1 Favipiravir Overall Market: 2023 VS 2024 VS 2030 4.2 Global Favipiravir Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Favipiravir Revenue and Market Share by Region (2019-2024) 4.2.2 Global Favipiravir Revenue Forecast by Region (2025-2030) 5 Global Favipiravir Market Size by Type and Application 5.1 Global Favipiravir Market Size by Type 5.2 Global Favipiravir Market Size by Application 6 North America 6.1 North America Favipiravir Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Favipiravir Market Size by Type 6.4 North America Favipiravir Market Size by Application 6.5 North America Favipiravir Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Favipiravir Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Favipiravir Market Size by Type 7.4 Europe Favipiravir Market Size by Application 7.5 Europe Favipiravir Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Favipiravir Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Favipiravir Market Size by Type 8.4 China Favipiravir Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Favipiravir Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Favipiravir Market Size by Type 9.4 APAC (excl. China) Favipiravir Market Size by Application 9.5 APAC (excl. China) Favipiravir Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Favipiravir Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Favipiravir Market Size by Type 10.4 Latin America Favipiravir Market Size by Application 10.5 Latin America Favipiravir Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Favipiravir Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Favipiravir Market Size by Type 11.4 Middle East & Africa Favipiravir Market Size by Application 11.5 Middle East & Africa Favipiravir Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Favipiravir Market Revenue by Key Manufacturers (2020-2024) 12.2 Favipiravir Competitive Landscape Analysis and Market Dynamic 12.2.1 Favipiravir Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 ChemRar Group 13.1.1 ChemRar Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 ChemRar Group Favipiravir Product Portfolio 13.1.3 ChemRar Group Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Glenmark 13.2.1 Glenmark Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Glenmark Favipiravir Product Portfolio 13.2.3 Glenmark Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Fujifilm 13.3.1 Fujifilm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Fujifilm Favipiravir Product Portfolio 13.3.3 Fujifilm Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Dr. Reddy 13.4.1 Dr. Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Dr. Reddy Favipiravir Product Portfolio 13.4.3 Dr. Reddy Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 R-Pharma 13.5.1 R-Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 R-Pharma Favipiravir Product Portfolio 13.5.3 R-Pharma Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Cipla 13.6.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Cipla Favipiravir Product Portfolio 13.6.3 Cipla Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Lupin 13.7.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Lupin Favipiravir Product Portfolio 13.7.3 Lupin Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Hisun Pharm 13.8.1 Hisun Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Hisun Pharm Favipiravir Product Portfolio 13.8.3 Hisun Pharm Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Sun Pharma 13.9.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Sun Pharma Favipiravir Product Portfolio 13.9.3 Sun Pharma Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Favipiravir Industry Chain Analysis 14.2 Favipiravir Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Favipiravir Typical Downstream Customers 14.4 Favipiravir Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support